TB-500 vs TB-500 Fragment (17-23): What’s the Difference?
The main difference between TB-500 and TB-500 Fragment (17-23) is mechanism: TB-500 is studied for systemic tissue repair and recovery research — Promotes cell migration, angiogenesis (new blood vessel formation), and rapid muscle/tissue repair. TB-500 Fragment (17-23) is studied for short active fragment of thymosin beta-4 — Binds G-actin and supports actin filament dynamics, which underlies cell migration to injury sites.
Full thymosin-β4 fragment vs short active stretch.
Key differences between TB-500 and TB-500 Fragment (17-23)
- •Mechanism: TB-500 — Promotes cell migration, angiogenesis (new blood vessel formation), and rapid muscle/tissue repair. TB-500 Fragment (17-23) — Binds G-actin and supports actin filament dynamics, which underlies cell migration to injury sites.
- •Primary research focus: TB-500 is studied for systemic tissue repair and recovery research; TB-500 Fragment (17-23) is studied for short active fragment of thymosin beta-4.
- •Overlap: the two compounds share healing & recovery.
- •Discussion context: TB-500 is most often discussed alongside systemic tissue repair and recovery research, while TB-500 Fragment (17-23) centres on short active fragment of thymosin beta-4.
| Attribute | TB-500 Thymosin Beta-4 fragment | TB-500 Fragment (17-23) TB4 17-23 / actin-binding fragment |
|---|---|---|
| Category | Healing & Recovery | Healing & Recovery |
| Best known for | Systemic tissue repair and recovery research | Short active fragment of thymosin beta-4 |
| Mechanism of action | Promotes cell migration, angiogenesis (new blood vessel formation), and rapid muscle/tissue repair. | Binds G-actin and supports actin filament dynamics, which underlies cell migration to injury sites. |
| Human research | Limited | Not catalogued |
| Animal research | Moderate | Not catalogued |
| Mechanistic research | Emerging | Not catalogued |
| Study cadence cited | 2× weekly during loading; weekly during maintenance | — |
| In plain English | If BPC-157 is the 'localized fixer,' TB-500 is the 'systemic upgrade.' Researchers study it for whole-body recovery effects, especially around cell migration and new blood vessel formation. | A condensed version of TB-500 that keeps the part of the molecule researchers believe drives cell migration and tissue repair. |
| How it works | TB-500 binds actin and promotes cell migration to injury sites. It's been studied for upregulating wound healing factors and modulating inflammatory responses. | Binds G-actin and supports actin filament dynamics, which underlies cell migration to injury sites. |
| Researchers study | Wound healing, cardiac tissue repair, hair follicle research, and post-injury recovery in animal models. | Wound healing, cell migration, and recovery models compared with full TB-500. |
| Internet discussion | Forum users describe TB-500 as the 'whole-body' counterpart to BPC-157. Anecdotes around acute injuries, post-surgery recovery, and even hair regrowth. | Discussed as a cheaper, simpler alternative to TB-500, though many users prefer full-length. |
Mechanism and research evidence, side by side
How TB-500 and TB-500 Fragment (17-23) differ at the receptor level, and how much published research currently supports each. Evidence ratings describe the depth of publicly available literature — they are not claims of safety or effectiveness.
TB-500
Promotes cell migration, angiogenesis (new blood vessel formation), and rapid muscle/tissue repair.
- Local growth-factor and angiogenic signalling
- Cell migration, matrix remodelling and inflammatory modulation
- Connective-tissue, gut-lining and wound-repair endpoints
- Human research
- Limited
- Animal research
- Moderate
- Mechanistic research
- Emerging
Systemic healing, soft tissue repair, recovery
TB-500
Systemic tissue repair and recovery research
If BPC-157 is the 'localized fixer,' TB-500 is the 'systemic upgrade.' Researchers study it for whole-body recovery effects, especially around cell migration and new blood vessel formation.
TB-500 binds actin and promotes cell migration to injury sites. It's been studied for upregulating wound healing factors and modulating inflammatory responses.
Wound healing, cardiac tissue repair, hair follicle research, and post-injury recovery in animal models.
Forum users describe TB-500 as the 'whole-body' counterpart to BPC-157. Anecdotes around acute injuries, post-surgery recovery, and even hair regrowth.
TB-500 is a systemic recovery research peptide studied for actin regulation, cell migration, and whole-body wound healing.
TB-500 Fragment (17-23)
Short active fragment of thymosin beta-4
A condensed version of TB-500 that keeps the part of the molecule researchers believe drives cell migration and tissue repair.
Binds G-actin and supports actin filament dynamics, which underlies cell migration to injury sites.
Wound healing, cell migration, and recovery models compared with full TB-500.
Discussed as a cheaper, simpler alternative to TB-500, though many users prefer full-length.
TB-500 Fragment 17-23 is a short actin-binding stretch of thymosin beta-4 studied as a simplified alternative to full-length TB-500.